tiprankstipranks
Advertisement
Advertisement

MEDGF Stock Latest News

Medacta lifts H1 2026 revenue 9.7% and confirms growth outlook
Company AnnouncementsMedacta lifts H1 2026 revenue 9.7% and confirms growth outlook
2d ago
PremiumCompany Announcements
Medacta Shareholders Approve All Proposals and CHF 21.9 Million Dividend at 2026 AGM
3M ago
Medacta Calls 2026 AGM With Dividend and Board Re-Elections on Agenda
PremiumCompany Announcements
Medacta Calls 2026 AGM With Dividend and Board Re-Elections on Agenda
4M ago
Medacta Uses Dinosaur “Hip Implant” Project as April Fools’ Showcase of Innovation
PremiumCompany Announcements
Medacta Uses Dinosaur “Hip Implant” Project as April Fools’ Showcase of Innovation
4M ago
Medacta Group price target raised to CHF 185 from CHF 182 at Berenberg
PremiumThe Fly
Medacta Group price target raised to CHF 185 from CHF 182 at Berenberg
5M ago
Medacta Delivers Record 2025 Results and Lifts Growth Targets on Broad-Based Orthopaedics Momentum
PremiumCompany AnnouncementsMedacta Delivers Record 2025 Results and Lifts Growth Targets on Broad-Based Orthopaedics Momentum
5M ago
Medacta Delivers 18.5% Constant-Currency Revenue Growth in 2025 on Broad-Based Demand
Premium
Company Announcements
Medacta Delivers 18.5% Constant-Currency Revenue Growth in 2025 on Broad-Based Demand
6M ago
Medacta Group price target raised to CHF 182 from CHF 175 at Berenberg
Premium
The Fly
Medacta Group price target raised to CHF 182 from CHF 175 at Berenberg
6M ago
Medacta’s MPACT DM Cup Study: A Potential Game-Changer in Hip Arthroplasty
PremiumCompany Announcements
Medacta’s MPACT DM Cup Study: A Potential Game-Changer in Hip Arthroplasty
9M ago
MEDGF
Medacta’s GMK SpheriKA Study: A Potential Game-Changer in Knee Prosthesis
PremiumCompany Announcements
Medacta’s GMK SpheriKA Study: A Potential Game-Changer in Knee Prosthesis
9M ago
MEDGF
Medacta’s SMS Femoral Stem Study: A Closer Look at Market Implications
PremiumCompany Announcements
Medacta’s SMS Femoral Stem Study: A Closer Look at Market Implications
9M ago
MEDGF
Medacta’s NextAR System: A Game Changer in Knee Arthroplasty?
PremiumCompany Announcements
Medacta’s NextAR System: A Game Changer in Knee Arthroplasty?
9M ago
MEDGF
Medacta’s Shoulder System Study: A Potential Game-Changer for Shoulder Treatments
PremiumCompany AnnouncementsMedacta’s Shoulder System Study: A Potential Game-Changer for Shoulder Treatments
9M ago
MEDGF
Medacta’s ROMAX Hip Resurfacing Study: A Potential Game-Changer for Orthopedic Market
Premium
Company Announcements
Medacta’s ROMAX Hip Resurfacing Study: A Potential Game-Changer for Orthopedic Market
9M ago
MEDGF
Medacta’s Innovative Shoulder System Trial: A Potential Game-Changer in Arthroplasty
Premium
Company Announcements
Medacta’s Innovative Shoulder System Trial: A Potential Game-Changer in Arthroplasty
9M ago
MEDGF
Medacta’s Innovative Hydrogel Coating: A Game-Changer for Joint Arthroplasty?
PremiumCompany Announcements
Medacta’s Innovative Hydrogel Coating: A Game-Changer for Joint Arthroplasty?
9M ago
MEDGF
Medacta’s Innovative Hip Implant Study: A Potential Game-Changer in Orthopedics
PremiumCompany Announcements
Medacta’s Innovative Hip Implant Study: A Potential Game-Changer in Orthopedics
9M ago
MEDGF
Medacta Group price target raised to CHF 175 from CHF 160 at Berenberg
PremiumThe Fly
Medacta Group price target raised to CHF 175 from CHF 160 at Berenberg
10M ago
Medacta Group price target raised to CHF 161 from CHF 159 at Morgan Stanley
PremiumThe Fly
Medacta Group price target raised to CHF 161 from CHF 159 at Morgan Stanley
11M ago
Medacta Group SA Reports Strong Growth in H1 2025
PremiumCompany AnnouncementsMedacta Group SA Reports Strong Growth in H1 2025
11M ago
Medacta Group SA Reports Robust H1 2025 Earnings
Premium
Company Announcements
Medacta Group SA Reports Robust H1 2025 Earnings
11M ago
Medacta Group SA Reports Strong H1 2025 Results with 19.8% Revenue Growth
Premium
Company Announcements
Medacta Group SA Reports Strong H1 2025 Results with 19.8% Revenue Growth
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >